Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: Double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA)

Sleep Medicine

Volumn 10, Issue 8, 2009, Pages 850-858

  Saletu, Michael ^a   Anderer, Peter ^a   Saletu Zyhlarz, Gerda Maria ^a   Mandl, Magdalena ^a   Saletu, Bernd ^a   Zeitlhofer, Josef ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Attention; Cognition; Event related potentials; LORETA; Modafinil; Narcolepsy; Prefrontal cortex

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; ARITHMETIC; ARTICLE; ATTENTION; AUDITORY CORTEX; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; ELECTROENCEPHALOGRAPHY; EPWORTH SLEEPINESS SCALE; EVENT RELATED POTENTIAL; FEMALE; GRAY MATTER; HUMAN; INFORMATION PROCESSING; LATENT PERIOD; MALE; NARCOLEPSY; NEUROIMAGING; ORIENTATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT OUTCOME; WAKEFULNESS;

ADULT; ATTENTION; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; ORIENTATION; PLACEBOS; PREFRONTAL CORTEX; REACTION TIME; TOMOGRAPHY; WAKEFULNESS; YOUNG ADULT;

EID: 68849132405     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.12.005     Document Type: Article

References (60)

1. Dang-Vu T.T., Desseilles M., Petit D., Mazza S., Montplaisir J., and Maquet P. Neuroimaging in sleep medicine. Sleep med 8 4 (2007) 349-372
2. Draganski B., Geisler P., Hajak G., Schuierer G., Bogdahn U., Winkler J., et al. Hypothalamic gray matter changes in narcoleptic patients. Nature medicine 8 11 (2002) 1186-1188
3. Kaufmann C., Schuld A., Pollmacher T., and Auer D.P. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology 58 12 (2002) 1852-1855
4. Overeem S., Steens S.C., Good C.D., Ferrari M.D., Mignot E., Frackowiak R.S., et al. Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep 26 1 (2003) 44-46
5. Brenneis C., Brandauer E., Frauscher B., Schocke M., Trieb T., Poewe W., et al. Voxel-based morphometry in narcolepsy. Sleep Medicine 6 6 (2005) 531-536
6. Nofzinger E.A. Neuroimaging the sleep disordered patient: a commentary. Sleep Med 6 5 (2005) 383-384
7. Pascual-Marqui R.D., Lehmann D., Koenig T., Kochi K., Merlo M.C., Hell D., et al. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Res 90 3 (1999) 169-179
8. Saletu B., Anderer P., Saletu-Zyhlarz G.M., Arnold O., and Pascual-Marqui R.D. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). Methods Find Exp Clin Pharmacol 24 Suppl. C (2002) 97-120
9. Saletu M., Anderer P., Saletu-Zyhlarz G.M., Mandl M., Arnold O., Zeitlhofer J., et al. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. J Neurol 251 11 (2004) 1354-1363
10. Pascual-Marqui R.D., Michel C.M., and Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 18 1 (1994) 49-65
11. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme 1988.
12. Arruda J.E., Walker K.A., Weiler M.D., and Valentino D.A. Validation of a right hemisphere vigilance system as measured by principal component and factor analyzed quantitative electroencephalogram. Int J Psychophysiol 32 2 (1999) 119-128
13. Näätänen R. Implications of event-related potentials data for psychological theories of attention. In: Renault MKM, Coles MGH, Gailland AGM editors. Event-related potentials investigations of cognition. Amsterdam: North Holland; 1989, p. 117-64.
14. Picton T., and Hillyard S. Endogenous event-related potentials. In: Picton T. (Ed). Human event-related potentials Handbook of electroencephalography and clinical neurophysiology (1988), Elsevier, Amsterdam 361-426
15. Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol 15 1 (1998) 14-33
16. Halgren E., Marinkovic K., and Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol 106 2 (1998) 156-164
17. Sangal R.B., and Sangal J.M. P300 latency: abnormal in sleep apnea with somnolence and idiopathic hypersomnia, but normal in narcolepsy. Clin Electroencephalogr 26 3 (1995) 146-153
18. Sangal R.B., Sangal J.M., and Belisle C. Longer auditory and visual P300 latencies in patients with narcolepsy. Clin Electroencephalogr 30 1 (1999) 28-32
19. Naumann A., Bierbrauer J., Przuntek H., and Daum I. Attentive and preattentive processing in narcolepsy as revealed by event-related potentials (ERPs). Neuroreport 12 13 (2001) 2807-2811
20. Mitler M.M., Harsh J., Hirshkowitz M., and Guilleminault C. Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med 1 3 (2000) 231-243
21. Minzenberg MJ, Carter CS. Modafinil: A Review of Neurochemical Actions and Effects on Cognition. Neuropsychopharmacology 2008;33(7):1477-502.
22. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43 1 (1998) 88-97
23. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54 5 (2000) 1166-1175
24. Harsh J.R., Hayduk R., Rosenberg R., Wesnes K.A., Walsh J.K., Arora S., et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Current medical research and opinion 22 4 (2006) 761-774
25. American Sleep Disorders Association. The International Classification of Sleep. Disorders, revised Diagnostic and Coding Manual. ed. Rochester; 1997
26. Johns M. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 14 6 (1991) 540-545
27. Mitler M.M., Gujavarty K.S., and Browman C.P. Maintenance of Wakefulness Test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 53 6 (1982) 658-661
28. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Brain Information Service, Los Angeles, University of California, 1968.
29. Squires N.K., Squires K.C., and Hillyard S.A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr Clin Neurophysiol 38 4 (1975) 387-401
30. Semlitsch H.V., Anderer P., Saletu B., Resch F., Presslich O., and Schuster P. Psychophysiological research in psychiatry and neuropsychopharmacology. I. Methodological aspects of the Viennese Psychophysiological Test-System (VPTS). Methods Find Exp Clin Pharmacol 11 1 (1989) 25-41
31. Anderer P., Semlitsch H.V., Saletu B., and Barbanoj M.J. Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology. Psychiatry Res 45 2 (1992) 79-93
32. Semlitsch H.V., Anderer P., Schuster P., and Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23 6 (1986) 695-703
33. Anderer P., Saletu B., Semlitsch H.V., and Pascual-Marqui R.D. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography). Methods Find Exp Clin Pharmacol. 24 Suppl. C (2002) 121-137
34. Abt K. Planning controlled clinical trials on the basis of descriptive data analysis. Statistics in medicine 10 5 (1991) 777-795
35. Ferber G., Abt K., Fichte K., and Luthringer R. IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group. Neuropsychobiology 39 2 (1999) 92-100
36. Cross E.M., and Chaffin W.W. Use of the binomial theorem in interpreting results of multiple tests of significance. Educational and Psychological Measurement. 42 (1982) 25-34
37. Lancester J.L., Rainey L.H., Summerlin J.L., Freitas C.S., Fox P.T., Evans A.C., et al. Automated labeling of the human brain a preliminary report on the development and evaluation of a forward transform method. Human Brain Mapping 5 (1997) 238-242
38. Saletu M, Anderer P, Saletu-Zyhlarz GM, Mandl M, Zeitlhofer J, Saletu B. Event-related potentials low-resolution brain electromagnetic tomography (ERP-LORETA) suggests decreased energetic resources for cognitive processing in narcolepsy. Clin Neurophysiol 2008;119(8):1782-94.
39. Sangal R.B., Sangal J.M., and Belisle C. Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy. Clin Neurophysiol 110 6 (1999) 1041-1047
40. Nagels G., D'hooghe M.B., Vleugels L., Kos D., Despontin M., and De Deyn P.P. P300 and treatment effect of modafinil on fatigue in multiple sclerosis. J Clin Neuroscience 14 (2007) 33-40
41. De Saint-Hilaire Z., Orosco M., Rouch C., Blanc G., and Nicolaidis S. Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. Neuroreport 12 16 (2001) 3533-3537
42. Ciliax B.J., Drash G.W., Staley J.K., Haber S., Mobley C.J., Miller G.W., et al. Immunocytochemical localization of the dopamine transporter in human brain. The Journal of comparative neurology 409 1 (1999) 38-56
43. Saletu B., Grünberger J., Linzmayer L., and Stöhr H. Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (Adrafinil) in elderlies. New Trends in Experimental Clinical Psychiatry 2 (1986) 5-31
44. Saletu B., Saletu M., Grünberger J., Frey R., Anderer P., and Mader R. Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology 27 1 (1993) 26-39
45. Schulz H., Wilde-Frenz J., and Grabietz-Kurfurst U. Cognitive deficits in patients with daytime sleepiness. Acta neurologica Belgica 97 2 (1997) 108-112
46. Smith K.M., Merrit S.L., and Cohen F.L. Can we predict cognitive impairment in persons with narcolepsy. Loss Grief Care 5 (1992) 103-113
47. Rieger M., Mayer G., and Gauggel S. Attention deficits in patients with narcolepsy. Sleep 26 1 (2003) 36-43
48. Naumann A., Bellebaum C., and Daum I. Cognitive deficits in narcolepsy. J Sleep Res 15 3 (2006) 329-338
49. Saletu M., Anderer P., Semlitsch H.V., Saletu-Zyhlarz G.M., Mandl M., Zeitlhofer J., et al. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Psychiatry Res 154 1 (2007) 69-84
50. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature medicine 6 9 (2000) 991-997
51. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 3 (2000) 469-474
52. Rogers A.E., and Rosenberg R.S. Tests of memory in narcoleptics. Sleep 13 1 (1990) 42-52
53. Valley V., and Broughton R. Daytime performance deficits and physiological vigilance in untreated patients with narcolepsy-cataplexy compared to controls. Revue d'electroencephalographie et de neurophysiologie clinique 11 1 (1981) 133-139
54. Duncan J., and Owen A.M. Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends in neurosciences 23 10 (2000) 475-483
55. Muzur A., Pace-Schott E.F., and Hobson J.A. The prefrontal cortex in sleep. Trends Cogn Sci 6 11 (2002) 475-481
56. Harrison Y., Horne J.A., and Rothwell A. Prefrontal neuropsychological effects of sleep deprivation in young adults-a model for healthy aging?. Sleep 23 8 (2000) 1067-1073
57. Ellis C.M., Monk C., Simmons A., Lemmens G., Williams S.C., Brammer M., et al. Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil. J Sleep Res 8 2 (1999) 85-93
58. Thomas R.J. Fatigue in the executive cortical network demonstrated in narcoleptics using functional magnetic resonance imaging-a preliminary study. Sleep Med 6 5 (2005) 399-406
59. Joo EY; Seo DW; Tae WS; Hong S.B. Effect of modafinil on cerebral blood flow in narcolepsy patients. Sleep 1,31 8 (2008) 868-873
60. Joo E.Y., Tae W.S., Jung K.Y., and Hong S.B. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study. J Sleep Res 17 1 (2008) 82-88